Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder
Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of ramelteon, once nightly
before bedtime (QHS), sublingual (SL), in the maintenance treatment of Bipolar I Disorder in
adult patients.